The AIS blog is a place to provide information and discussion about a range of issues that are relevant to the service. It is also an opportunity to discuss relevant research, publications, and guidelines.
Most of us will consume caffeine in some form, but what if it could reduce symptoms of OCD? A recent study (Naftalovich et al, 2020) explored whether caffeine could help inhibition - which includes the ability to suppress or change intrusive thoughts. Here, we look at this study to see whether...Read More
It is fairly well known that people with OCD have symptoms for a long time before seeking help, and wait longer before receiving effective treatment. In light of a new study from Brazil about the speed of development of OCD symptoms (Thompson et al, 2020), I review the evidence that highlights these...Read More
In this blog, I review six randomised, controlled trials comparing N-Acetylcysteine (NAC) versus placebo for the treatment of OCD. NAC is a glutamate regulator and has good tolerability. Four trials tested it in adults, and two tested it in children.Read More
The pandemic has had a dramatic effect on the whole of the NHS, but it has also affected the availability of services for OCD. Not only that, but the nature of the pandemic will have had effects on many people with OCD; particularly those with contamination obsessions and cleaning compulsions. In this...Read More
People sometimes wonder how severe patients being seen by a specialist service are. The following is a description of the severity of symptoms that individuals seen by the AIS present with, based on a relatively large sample of patients seen over the last 14 years.Read More
Earlier this year, a group of OCD experts and specialists published guidelines on managing OCD during COVID-19. It was quickly becoming evident that traditional exposure and response prevention (ERP) was going to be very difficult to deliver during a pandemic. We present some information on how...Read More